SCHEMBL528665

SCHEMBL528665

CCC(N[C]=O)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8122099 0.78 FDPS (0.30)
SCHEMBL181414 0.72 PRMT3 (0.33)
SCHEMBL1081915 0.69
SCHEMBL4786657 0.69
SCHEMBL269617 0.67
SCHEMBL11471941 0.67
SCHEMBL25179 0.65
SCHEMBL28074882 0.65 TDP1 (0.39)
SCHEMBL18553317 0.65 LMNA (0.31)
SCHEMBL1685481 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487494-B2 Cyclic hydrocarbon compounds for the treatment of diseases LEO PHARMA A/S (DK) 2016-11-08 US claimed
EP-2597955-B1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE INC (JP) 2016-01-20 EP claimed
US-9120749-B2 Quinoline derivatives and MELK inhibitors containing the same ONCOTHERAPY SCIENCE, INC. (JP) 2015-09-01 US claimed
US-20130217671-A1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE, INC. (JP) 2013-08-22 US claimed
EP-2597955-A1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME OncoTherapy Science, Inc. (JP) 2013-06-05 EP claimed
WO-2012016082-A1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE, INC. (JP) 2012-02-02 WO claimed
US-20100317582-A1 NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2010-12-16 US claimed
EP-2234961-A2 NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2010-10-06 EP claimed
WO-2009065406-A2 NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2009-05-28 WO claimed
EP-1963331-A1 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS Exelixis, Inc. (US) 2008-09-03 EP claimed
WO-2007070796-A1 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS, INC. (US) 2007-06-21 WO claimed
EP-1131318-B1 PROCESS FOR MAKING 5-SUBSTITUTED PYRAZOLES USING DITHIETANES SEARLE LLC (US) 2004-03-24 EP claimed
EP-2954373-B1 CHEMICAL COATING FOR A LASER-MARKABLE MATERIAL FUJIFILM HUNT CHEMICALS US INC (US) 2019-04-24 EP disclosed
US-9487494-B2 Cyclic hydrocarbon compounds for the treatment of diseases LEO PHARMA A/S (DK) 2016-11-08 US disclosed
EP-2597955-B1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE INC (JP) 2016-01-20 EP disclosed
EP-2954373-A1 CHEMICAL COATING FOR A LASER-MARKABLE MATERIAL Fujifilm Hunt Chemicals US, Inc. (US) 2015-12-16 EP disclosed
EP-0685530-B1 Process for producing dioxazine compounds, colored materials therewith and dioxazine compounds having a plate-like crystal form NIPPON KAYAKU KK (JP) 2000-01-12 EP disclosed
US-5859242-A ORGANIC PIGMENTS FOR INKS AND PAINTS NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1999-01-12 US disclosed
US-5734050-A CYCLIZING SUBSTITUTED BIS/CARBAZOLYLAMINO/-1,4-BENZOQUINONE IN PRESENCE OF DIOXAZINE DERIVATIVE NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1998-03-31 US disclosed
EP-0685530-A1 Process for producing dioxazine compounds, colored materials therewith and dioxazine compounds having a plate-like crystal form Nippon Kayaku Kabushiki Kaisha (JP) 1995-12-06 EP disclosed